CNO Financial Group (CNO)
(Delayed Data from NYSE)
$34.97 USD
+0.57 (1.66%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $34.98 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth F Momentum C VGM
Price, Consensus and EPS Surprise
CNO 34.97 +0.57(1.66%)
Will CNO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CNO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CNO
Here's Why You Should Hold on to Marsh & McLennan Stock for Now
Should Value Investors Buy CNO Financial Group (CNO) Stock?
CNO: What are Zacks experts saying now?
Zacks Private Portfolio Services
CNO Financial's Washington National Enhances Insurance Product
CNO Financial (CNO) is a Great Momentum Stock: Should You Buy?
Everest Group Stock Lags Industry YTD: Should You Hold or Fold?
Other News for CNO
Analyst Expectations For CNO Finl Group's Future
Piper Sandler Reaffirms Their Buy Rating on CNO Financial (CNO)
CNO Financial price target raised by $1 at Piper Sandler, here's why
Washington National Introduces New Hospital Indemnity Insurance Product
Dividend Champion, Contender, And Challenger Highlights: Week Of September 22